WCG Buys E-clinical Software and Translation Provider VeraSci
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
Slator’s 2019 report on the clinical life sciences translation industry, analysis of the competitive landscape and actionable insights from major buyers of pharmaceutical translation.
Adelina Lear of contract research organization ICON plc spoke at SlatorCon London on the role of language services and the linguistic validation workflow in clinical trials.
Your information will never be shared with third parties. No Spam.